Related Experiment Video
Updated: Jan 20, 2026

DCE-MRI of Orthotopic Pancreatic Tumor Xenografts: A Method to Assess Microvasculature in a Target Tumor Tissue
Published on: April 30, 2023
A novel method for pharmacokinetic parameters quantification in DCE-MRI: Application in prostate cancer
Jhonalbert Aponte1, Álvaro Ruíz1, Jacksson Sánchez2
1Hospital Oncológico Fundación Arturo López Pérez, Santiago de Chile, Chile.
Background:
Detecting and quantifying tumor vascularity is critical for diagnosing cancer, guiding therapy, and monitoring disease progression.
Purpose:
This study focuses on quantifying pharmacokinetic parameters derived from multi-compartment models by analyzing and processing dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) data of prostate cancer lesions.
Methods:
Previous voxel-based analysis employed the three-time-point method to classify different regions based on kinetic patterns. The key pharmacokinetic parameters-such as , the vascular elimination rate, and , the extravascular transfer rate, were extracted using a novel point-wise interpolation method designed for application in compartmental models.
Results:
Results from the simple two-compartment model proposed by Brix revealed the presence of both fast and slow exchange regions, suggesting the potential for a more complex multi-compartment model. Parameter distribution maps generated from this analysis appear to correlate with pathological and unaffected glandular regions. Further investigation using a three-compartment model identified an additional exchange rate that lies between the previously observed fast and slow rates, supporting the assumption of tissue heterogeneity beyond the two-compartment framework.
Conclusions:
A simple two-compartment model can effectively describe the kinetics of contrast media. When combined with a novel voxel-wise method, it enables the estimation of tissue exchange parameters and their spatial distributions. These results have potential applications in the diagnostic evaluation and therapeutic monitoring of prostate cancer.
Related Concept Videos
04:11DCE-MRI of Orthotopic Pancreatic Tumor Xenografts: A Method to Assess Microvasculature in a Target Tumor Tissue
09:11Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy
04:37Sampling Prostate Cancer Tissue for Biobanking: An MRI-guided Targeted Technique to Remove Biopsy Punches from Fresh Tumor Tissue
11:07Focal Laser Ablation of Prostate Cancer: An Office Procedure
07:16Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
05:07Intra-prostatic Injection of Cancer Cells: A Technique to Deliver Cancer Cells for Establishing Orthotopic Prostate Cancer Mouse Model

